Global Bioburden Testing Market is anticipated to witness value over USD 1.3 billion during the forecast period 2019 to 2026 with a CAGR of over 11%.

Bioburden testing is the study of the microbial count present on the surface of any material or product. The term is used for testing the contamination in pharmaceutical products, food and beverages, medical devices, etc. Bioburden testing is mandatory as per ICH (International Conference on Harmonization) guidelines for the manufacturing and distribution of food and drugs along with medical devices.

For an FDA ( Food and Drug Administration) approval the bioburden testing as per ICH guidelines must be followed. This is the key factor driving the bioburden testing market. 

Growth in the pharmaceutical products, food and beverages, medical devices across the globe are factors contributing to bioburden market growth and are positively influencing the CAGR. The risk of microbial contamination in healthcare products and hence the related safety concerns can not be ignored. It is the key factor driving the market.

The consumables like culture media and reagents are estimated to contribute as a major part of the market growth across the globe. Culture media and reagents are basic ingredients used for bioburden testing. Any negligence in the safety and sterility conditions of the product creates severe health problems and a huge loss in the market. To avoid such consequences, bioburden testing is the key.

The contamination in raw materials is detected by anaerobic count testing. The safety and economic concerns related to raw materials have driven the preference for anaerobic count testing in the market. The rising demand for anaerobic count testing is one of the key elements driving its contribution to the bioburden testing market. 

Pharmaceutical and biotechnology companies contribute to the large share of the bioburden testing market worldwide. Pharma companies involve bioburden testing at every step of manufacturing starting from raw materials to finished products. This is the major feature that drives the growth of the bioburden testing market.

North America is estimated to hold a large share in the bioburden testing market. The rise in research and development activities and massive investments in these activities play a major role in market growth. The increasing scope for pharma industries in Asia Pacific is one of the dominating factors responsible for the market to grow.

The major companies are Charles River, Merck KGaA, SGS SA, Wuxi Apptec and so on. Merck KGaA is one of the major key players in the bioburden testing market. It has a range of testing facilities for food and beverages, pharmaceuticals, clinical and diagnostics, and so on.

FutureWise Key Takeaways:

●    New advancements in bioburden testing methods

●    Investment in bioburden consumables products

●    Collaboration bioburden testing organizations

Global Bioburden Testing Market Segmentation:

By Product

●    Consumables

●    Instruments

By Test Type

●    Aerobic count testing

●    Anaerobic count testing

●    Fungi/ Mold count testing

●    Spore count testing

By Application

●    Raw material testing

●    Medical device testing

●    In-process material testing

●    Sterilization validation testing

●    Equipment cleaning validation

By End User

●    Pharmaceutical and biotechnology companies

●    Medical device manufacturers

●    Contract manufacturing organizations

●    Manufacturers of Food & Beverage and Agricultural Products

●    Microbial Testing Laboratories

By Region

●    North America

●    Europe

●    Asia Pacific

●    Rest of the world

Competitive Landscape:

●    Tier 1 players- established companies in the market with a major market share

●    Tier 2 players

●    Emerging players which are growing rapidly

●    New Entrants

Objectives of the Study:

●    To provide with an exhaustive analysis on the bioburden testing market by product, by test type, by application, by end user and by region

●    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

●    To evaluate and forecast micro-markets and the overall market

●    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, and the rest of the world

●    To record evaluate and competitive landscape mapping-product launches, technological advancements, mergers and expansions

●    Profiling of companies to evaluate their market shares, strategies, financials and core competencies



Need Assistance


UK : +44 141 628 9353
US : +1 970 279 4295


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics